Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
a step » _ step (Expand Search)
10 mg » 100 mg (Expand Search), 50 mg (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
mg decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
a step » _ step (Expand Search)
10 mg » 100 mg (Expand Search), 50 mg (Expand Search)
-
21
Dyspnea-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
22
Gradient-Janus Wires for Simultaneous Fogwater Harvesting and Electricity Generation
Published 2024Subjects: -
23
Gradient-Janus Wires for Simultaneous Fogwater Harvesting and Electricity Generation
Published 2024Subjects: -
24
Gradient-Janus Wires for Simultaneous Fogwater Harvesting and Electricity Generation
Published 2024Subjects: -
25
Respiratory symptoms-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
26
Other symptoms-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
27
Gastrointestinal symptoms-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
28
-
29
-
30
-
31
-
32
-
33
Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease.
Published 2025“…<p>Effective contact rate over time for the different modelling scenarios considered: fixed, continuously increasing, continuously decreasing and with a step-decrease.</p>…”
-
34
The percentage of NaCl tolerant <i>E</i>. <i>coli</i> cells retained on filters.
Published 2019Subjects: -
35
-
36
-
37
Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints.
Published 2020“…<p>Odds ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
-
38
-
39
-
40